STOCKWATCH
·
Pharmaceuticals
New Launch18 Sept 2025, 04:29 pm

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India

AI Summary

Sai Life Sciences, an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced the opening of Unit VI, a dedicated facility for veterinary API production, in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies.

Key Highlights

  • Sai Life Sciences opens a dedicated facility for veterinary API production in Bidar, India.
  • The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance.
  • The facility aims to provide efficient and scalable manufacturing solutions to leading global animal health companies.
  • Sai Life Sciences has over two decades of manufacturing expertise and is known for its advanced process capabilities, operational excellence, and stringent quality standards.
  • The new facility leverages advanced technologies, robust supply chain management, and best-in-class safety practices.
SAILIFE
Pharmaceuticals
Sai Life Sciences Ltd

Price Impact